Showing results (51-60 of 55) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 55 results.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 22, 2013
A randomized, double-blind, phase II study of erlotinib with or without sunitinib for the second-line treatment of metastatic non-small-cell lung cancer (NSCLC)H J M Groen, M A Socinski, F Grossi, et al.ESMO Open|April 19, 2024
A phase I study to evaluate the safety, pharmacokinetics, and pharmacodynamics of PF-06939999 (PRMT5 inhibitor) in patients with selected advanced or metastatic tumors with high incidence of splicing factor gene mutationsJ Rodon, E Rodriguez, M L Maitland, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 22, 2011
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancerE F Smit, M A Socinski, B P Mullaney, et al.Clinical Pharmacology and Therapeutics|May 1, 2014
Erlotinib in African Americans with advanced non-small cell lung cancer: a prospective randomized study with genetic and pharmacokinetic analysesM A Phelps, T E Stinchcombe, J S Blachly, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|June 16, 2018
Predictive biomarkers for response to EGFR-directed monoclonal antibodies for advanced squamous cell lung cancerP D Bonomi, D Gandara, F R Hirsch, et al.Pageof 6